期刊文献+

耐甲氧西林葡萄球菌对大环内酯类抗生素的耐药性分析 被引量:3

Analysis of resistance of methicillin resistant staphylococcus to macrolides
暂未订购
导出
摘要 目的研究耐甲氧西林葡萄球菌(MRS)对大环内酯类(M)-林可酰胺类(L)-链阳菌素类(S)抗生素(MLS)的耐药性,以指导临床用药。方法采用K—B扩散法测定90株MRS临床分离株的MLS六种代表药物的药敏试验,分析其耐药率和药敏表型。结果MRS的红霉素、阿齐霉素耐药率一致,均达93.00%以上,麦迪霉素、乙酰螺旋霉素达71.00%以上,克林霉素达68.00%以上,未见奎奴普丁/达福普丁(QD)耐药。MRS对MLS有5种药敏表型,最主要的表型为ML耐药/S敏感(71.11%);MRSA和MRCNS的药敏表型分布不一样。结论MRS的红霉素、阿齐霉素耐药率一致,但其它MLS4种代表药物耐药率不一致且较高;MRS对MLS有5种药敏表型,最主要的表型为ML耐药/S敏感;MRSA和MRCNS的药敏表型分布不一样。 Obejective:To study resistance of methicillin resistant staphylococcus(MRS)to macrolides(M)-lin-cosamides(L)-streptogramins(S)(MLS).Methods:TO detect the susceptibility of90MRS strains with K-B diffu-sion test,analyse the resistant rates and phenotypes.Results:The resistant rates of MRS to Erythromycin and Azithromycin were similary,more than93%,Midecamycin and Ethylspiramycin more than71%,Clindamycin more than68%,no QD resistant.There were five resistant phenotypes of MRS to MLS,the main phenotypes was ML re-sistant/S susceptibility,no phenotype of Erythromycin and Azithromycin/Midecamycin,Ethylspiramycin,Clin-damycin,QD resistant;the phenotypes of MRSA,MRCNS were difference,there were not all-susceptibility and all-resistant phenotypes in MRSA.Conclusions:The resistant rates of MRS to Erythromycin and Azithromycin are simi-lary,other difference,and high;There are five resistant phenotypes of MRS to MLS,the main phenotypes is ML re-sistant/S susceptibility,the phenotypes of MRSA,MRCNS are difference.
出处 《中国现代医学杂志》 CAS CSCD 2004年第22期100-101,共2页 China Journal of Modern Medicine
关键词 葡萄球菌 大环内酯类 林可酰胺类 链阳菌素类 甲氧西林 staphylococcus methicillin macrolides lincosamides streptogramins
  • 相关文献

参考文献5

二级参考文献3

共引文献48

同被引文献23

  • 1巴特尔,郭淑英,张亚荣.耐甲氧西林凝固酶阴性葡萄球菌产酶耐药基因分子流行病学研究[J].中华医院感染学杂志,2005,15(6):605-607. 被引量:21
  • 2National committee for clinical laboratory standards. Performance Standards for Antimicrobial Disk Susceptibility Tests[S]. M100- S12,NCCLS, 2002. 1-133.
  • 3瞿亚红,姜妙静,周程程.不同种类标本分离的金黄色葡萄球菌的耐药性比较及分析.2014年浙汀省检验医学学术年会论文汇编,2014.
  • 4Lavall6e C, Rouleau D, Gaudreau C, et al. Performance of an agar dilution method and a Vitek 2 card for detection of inducible clindamycinresistance in Staphylococcus spp. ] Clin Microbiol, 2010, 48(4): 1354-1357.
  • 5Cetin ES, Gunes H, Kaya S, et al. Macrolide-lincosamide- streptogramin B resistance phenotypes in clinical staphylococcal isolates, lnt ] Antinticrob Agents, 2008, 31 (4): 364-368.
  • 6Matsuoka M. Study of macrolide, lincosamide, and streptogramin B antibiotics resistance in Staphylococcus aureus. Yakugaku Zasshi, 2000, 120(4): 374-386.
  • 7Uzun B, G/ing6r S, Pekta~ B, et al. Macrolide-lincosamide- streptogramin B (MLSB) resistance phenotypes in clinical Staphylococcus isolates and investigation of telithromycin activity. Mikrobi),ol Bul, 2014, 48(3): 469-476.
  • 8National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests. M100-S15, NCCLS, 2005: 1-133.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; Twentieth informational supplement. CLSI documents M 100-$20. CLSI, 2010.
  • 10胡志东,王凤霞,李金,李静,徐海茹,田彬.2010年度卫生部全国细菌耐药监测网报告:伤口感染病原菌分布及耐药监测[J].中华医院感染学杂志,2012,22(1):23-27. 被引量:20

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部